- Home
- BBDO vs WST Comparison
BBDO vs WST Comparison
Compare BBDO & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BBDO | WST |
|---|---|---|
| Founded | 1943 | 1923 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.0B | 27.9B |
| IPO Year | 2002 | 2004 |
Fundamental Metrics
Financial Performance| Metric | BBDO | WST |
|---|---|---|
| Price | $2.36 | $416.04 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 16 |
| Target Price | N/A | ★ $471.00 |
| AVG Volume (30 Days) | 226.2K | ★ 692.3K |
| Earning Date | 10-22-2026 | 10-29-2026 |
| Dividend Yield | ★ 7.78% | 0.25% |
| EPS Growth | N/A | ★ 1.49 |
| EPS | N/A | ★ 7.09 |
| Revenue | N/A | ★ $2,886,900,000.00 |
| Revenue This Year | $9.64 | $11.26 |
| Revenue Next Year | $6.39 | $5.92 |
| P/E Ratio | ★ $9.20 | $58.03 |
| Revenue Growth | N/A | ★ 1.95 |
| 52 Week Low | $2.30 | $223.83 |
| 52 Week High | $4.16 | $438.27 |
Technical Indicators
Market Signals| Indicator | BBDO | WST |
|---|---|---|
| Relative Strength Index (RSI) | 30.18 | 65.72 |
| Support Level | $2.30 | $386.88 |
| Resistance Level | $3.20 | $438.27 |
| Average True Range (ATR) | 0.10 | 11.84 |
| MACD | -0.02 | -0.12 |
| Stochastic Oscillator | 9.09 | 56.80 |
Price Performance
Historical ComparisonAbout BBDO Banco Bradesco Sa
Banco Bradesco is Brazil's second-largest private bank, with about 10%-15% of deposits, and the largest insurance provider in Brazil, with roughly 20%-25% market share. The bank is majority controlled by the Bradesco foundation, a private nonprofit institution focused on education. The bank is also a major asset manager with high-single-digit market share. In 2016, Bradesco acquired the Brazilian operations of HSBC.
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.